Pro Medicus Limited

Equities

PME

AU000000PME8

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:21 2024-04-16 am EDT 5-day change 1st Jan Change
102 AUD -4.09% Intraday chart for Pro Medicus Limited -7.26% +6.44%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Pro Medicus Limited authorizes a Buyback Plan. CI
Pro Medicus Limited announces an Equity Buyback for 10,442,488 shares, representing 10% of its issued share capital. CI
Pro Medicus Limited(ASX:PME) added to S&P/ASX 100 Index CI
Pro Medicus Limited(ASX:PME) dropped from S&P/ASX Small Ordinaries Index CI
Pro Medicus Limited authorizes a Buyback Plan. CI
Pro Medicus Limited announces an Equity Buyback for 11,300 shares, representing 0.01% of its issued share capital. CI
Transcript : Pro Medicus Limited, H1 2024 Earnings Call, Feb 15, 2024
Pro Medicus' Net Profit, Revenue Jumps in Fiscal H1 MT
Pro Medicus Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Pro Medicus' US Arm Launches Computing Platform for Apple MT
Pro Medicus' Co-Founders Each Sell One Million Shares MT
Pro Medicus Seeks Acquisitions CI
Transcript : Pro Medicus Limited - Shareholder/Analyst Call
Pro Medicus' US Subsidiary Secures AU$20 Million Deal from Oregon Health & Science University MT
Australian shares snap three-day losing run to rise on strong commodity stocks RE
Pro Medicus' US Subsidiary Signs AU$16 Million Contract with South Shore Health MT
Pro Medicus' Net Profit Jumps 37% in Fiscal Year 2023 MT
Transcript : Pro Medicus Limited, 2023 Earnings Call, Aug 15, 2023
Pro Medicus Limited Announces an Fully Franked Ordinary Dividend for the Period of Twelve Months Ended June 30, 2023, Payable on September 28, 2023 CI
Pro Medicus Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Pro Medicus Signs AU$24 Million Medical Imaging Deal with US Cancer Center MT
Pro Medicus Starts Share Buyback Program MT
Pro Medicus Limited announces an Equity Buyback for 10,443,225 shares, representing 10% of its issued share capital. CI
Pro Medicus Limited authorizes a Buyback Plan. CI
Tranche Update on Pro Medicus Limited's Equity Buyback Plan announced on April 1, 2022. CI
Chart Pro Medicus Limited
More charts
Pro Medicus Limited is an Australia-based healthcare informatics company. The Company provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
106.4 AUD
Average target price
95.57 AUD
Spread / Average Target
-10.13%
Consensus
  1. Stock Market
  2. Equities
  3. PME Stock
  4. News Pro Medicus Limited
  5. Pro Medicus to Provide Enterprise Imaging Platform to US-based Healthcare Non-Profit in $20 Million Deal